Direxion Daily S&P Biotech Bull 3x Shares Rating $65.52 +0.20 (+0.31%) Closing price 04:10 PM EasternExtended Trading$65.56 +0.04 (+0.05%) As of 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ratings Stock AnalysisChartDividendHoldingsOwnershipRatingsShort InterestBuy This Stock Direxion Daily S&P Biotech Bull 3x Shares Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.LABU Aggregate RatingModerate Buy 2.65Holdings in LABU have an aggregate rating of Moderate Buy based on 401 analyst ratings issued in the past year covering 19 companies (29.1% of the portfolio).LABU Aggregate Price Target$65.52High Prediction$65.52Average Prediction$65.52Low Prediction$65.52Holdings in LABU have an aggregate price target of $65.52 and a range of $65.52 to $65.52 covering 19 companies (29.1% of the portfolio).LABU Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy3 Buy rating(s)Moderate Buy11 Moderate Buy rating(s)Hold5 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Direxion Daily S&P Biotech Bull 3x Shares Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 19 LABU Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings1.73%MRNAModerna$34.15+0.4%4.2501 of 5 stars2.04$46.11 35.0%25Upcoming EarningsAnalyst Forecast1.62%ALNYAlnylam Pharmaceuticals$328.81+0.2%4.0506 of 5 stars2.81$347.75 5.8%26Upcoming Earnings1.62%EXELExelixis$45.60+1.8%4.7823 of 5 stars2.52$45.33 -0.6%21Positive NewsUpcoming EarningsAnalyst Forecast1.61%HALOHalozyme Therapeutics$58.24-0.9%4.8487 of 5 stars2.17$62.70 7.7%12Positive News1.61%NBIXNeurocrine Biosciences$132.14+0.4%4.5072 of 5 stars2.88$163.87 24.0%24Upcoming EarningsAnalyst Forecast1.61%UTHRUnited Therapeutics$304.50-0.6%4.9917 of 5 stars2.69$383.08 25.8%13News CoveragePositive NewsUpcoming EarningsInsider TradeAnalyst Revision1.60%INSMInsmed$103.95+0.4%3.9532 of 5 stars3.00$109.20 5.1%17Positive NewsAnalyst ForecastInsider Trade1.58%REGNRegeneron Pharmaceuticals$563.10-0.3%4.8259 of 5 stars2.75$828.86 47.2%24Trending NewsUpcoming EarningsAnalyst Forecast1.55%VRTXVertex Pharmaceuticals$469.65-0.6%4.3209 of 5 stars2.52$512.30 9.1%27Positive NewsAnalyst Revision1.53%AMGNAmgen$306.58-0.6%4.3987 of 5 stars2.35$307.27 0.2%23Positive NewsAnalyst Forecast1.53%BMRNBioMarin Pharmaceutical$59.01-1.3%4.9865 of 5 stars2.75$93.74 58.9%24Analyst Forecast1.51%INCYIncyte$70.20-0.4%4.5409 of 5 stars2.22$74.47 6.1%18Positive NewsUpcoming EarningsInsider Trade1.50%GILDGilead Sciences$116.20+2.7%4.8433 of 5 stars2.81$112.36 -3.3%26Trending NewsAnalyst Upgrade1.49%ABBVAbbVie$190.22-0.3%4.8419 of 5 stars2.81$211.29 11.1%27Trending NewsUpcoming EarningsAnalyst Revision1.45%BIIBBiogen$131.52-0.8%4.8471 of 5 stars2.34$186.37 41.7%32Upcoming EarningsAnalyst Revision1.44%EXASExact Sciences$48.49-0.6%4.7517 of 5 stars2.95$70.50 45.4%22Positive News1.44%BBIOBridgeBio Pharma$46.30+1.4%4.6243 of 5 stars3.00$61.50 32.8%161.33%NTRANatera$138.90-1.5%2.5557 of 5 stars3.00$184.63 32.9%15News CoverageInsider TradeAnalyst Revision1.32%MDGLMadrigal Pharmaceuticals$298.40-0.3%4.2728 of 5 stars2.89$420.63 41.0%9Insider Trade This page (NYSEARCA:LABU) was last updated on 7/25/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredTrump’s betrayal exposed Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredTreasury Secretary Bessent Is Betting Big on GoldWhen the U.S. Treasury Secretary’s largest personal investment is gold — that’s a signal. Now a veteran gol...Golden Portfolio | SponsoredTurn $1K into $50K with This DeFi GemI've never been more confident about a DeFi opportunity. This isn't about complex trading or risky bets. Th...Crypto 101 Media | SponsoredHow to Collect Up To $5,917/mo From Trump’s Made In USA BoomHow to Collect Up To $5,917/mo From Trump's Made In USA Boom Thanks to President Trump's America-First poli...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Direxion Daily S&P Biotech Bull 3x Shares Please log in to your account or sign up in order to add this asset to your watchlist. Share Direxion Daily S&P Biotech Bull 3x Shares With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free LABU Stock Alerts